Evidence map›Paper›PMID 32864381›Full record

ArticleERJ open research2020

Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients.

Soodaba Mir, Jean Wong, Clodagh M Ryan, Geoff Bellingham, Mandeep Singh, Rida Waseem, Danny J Eckert, Frances Chung

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Soodaba MirDept of Anesthesia and Pain Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Jean WongDept of Anesthesia and Pain Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Clodagh M RyanCentre of Sleep Health and Research, Dept of Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-2372-965X
Geoff BellinghamDept of Anesthesia and Perioperative Medicine, St Joseph's Health Care, Western University, London, ON, Canada.
Mandeep SinghDept of Anesthesia and Pain Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Rida WaseemDept of Anesthesia and Pain Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Danny J EckertAdelaide Institute for Sleep Health, Flinders University, Bedford Park, SA, Australia.ORCID https://orcid.org/0000-0003-3503-2363
Frances ChungDept of Anesthesia and Pain Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
University Health Network · CAFlinders University · AUWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe concurrent use of sedating centrally acting drugs and opioids by chronic pain patients occurs routinely despite concerns of negative impacts on respiration during sleep. The effects of centrally acting drugs and opioids on sleep apnoea have not been well characterised. The objective of this study was to assess the effect of concomitant centrally acting drugs and opioids on the prevalence and severity of sleep apnoea in chronic pain patients.

methodsWe conducted a prospective cohort study at five chronic pain clinics. Each participant underwent an in-laboratory polysomnography and daily morphine milligram equivalents were calculated. Participants were grouped into centrally acting drugs and opioid users

resultsOf the 332 consented participants, 204 underwent polysomnography and 120 (58.8%) had sleep apnoea (72% obstructive, 20% central, and 8% indeterminate sleep apnoea). Overall, 35% (71 of 204) were taking opioids alone, and 65% (133 of 204) were taking centrally acting drugs and opioids. There was a 69% decrease in the odds of having sleep apnoea (apnoea-hypopnoea index ≥5 events·h

conclusionIn chronic pain patients on opioids, administration of certain benzodiazepine sedatives induced a mild respiratory depression but paradoxically reduced sleep apnoea risk and severity by increasing the respiratory arousal threshold.

Identifiers

PMID32864381
PMCPMC7445118
OpenAlexW3081085189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.